Anuncio
Anuncio
MXCT
MaxCyte, Inc. Common Stock
1.43
USDPatrocinado
-0.03
-2.38%
09 ene, 15:48 UTC -5
Cerrado
Pre-mercado
1.45
+0.02
+1.47%
Informes de beneficios de MXCT
Ratio de Sorpresa Positivo
MXCT superó 15 de las últimas 18 estimaciones.
83%
Próximo informe
Fecha del próximo informe
02 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.59M
/-$0.08
Cambio implícito desde Q3 25 (Revenue/ EPS)
+40.49%
/-11.11%
Cambio implícito desde Q4 24 (Revenue/ EPS)
+10.37%
/-20.00%
MaxCyte, Inc. Common Stock earnings per share and revenue
On 12 nov 2025, MXCT reported earnings of -0.09 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 19.79% surprise. Revenue reached 6.83 millón, compared to an expected 8.54 millón, with a -20.01% difference. The market reacted with a -4.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -0.08 USD, with revenue projected to reach 9.59 millón USD, implying an reducir of -11.11% EPS, and aumentar of 40.49% in Revenue from the last quarter.
Preguntas frecuentes
What were MaxCyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MaxCyte, Inc. Common Stock reported EPS of -$0.09, beating estimates by 19.79%, and revenue of $6.83M, -20.01% below expectations.
How did the market react to MaxCyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.43%, changed from $1.58 before the earnings release to $1.51 the day after.
When is MaxCyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02 mar 2026.
What are the forecasts for MaxCyte, Inc. Common Stock's next earnings report?
Based on 8
analistas, MaxCyte, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $9.59M for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio